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Objective: The aim of this study is to determine the diagnostic accuracy of multidetector-row computed
tomography (MDCT) compared to histopathological ﬁndings in tumor staging of renal cell carcinoma,
with the focus on tumor size and stage, renal vein involvement, and peri-renal inﬁltration.
Materials and methods: In a retrospective study, a total of 98 consecutive patients with renal cell carci-
noma were preoperatively assessed for tumor staging using multidetector-row CT. Triphasic CT imaging
(i.e., noncontrast, arterial, and parenchymal phase) was performed using multidetector-row CT with the
slice thickness of 5 mm and using multi planar reconstructions to deﬁne the tumor characteristics. A
single blinded reader evaluated the CT scans independently who reviewed the scan on multi planar
reconstructions. The results were then correlated with the histopathological results.
Results: A total of 98 renal cell carcinomas were proven on histopathology. There was a signiﬁcant
(p 0.05) difference in the mean maximum radiological and maximum pathological diameter of the tumor
with radiological diameter being greater. Twenty seven tumors were down staged and only 1 was up
staged. The speciﬁcity of CT for capsular invasion, nodal disease and adrenal involvement was 85, 82 and
98% respectively. The speciﬁcity was over 97% for tumor thrombus in renal vein and IVC.
Conclusions: The multi planar reconstruction capability of multidetector-row CT allowed good speciﬁcity
in predicting renal vein, IVC involvement, capsular invasion and nodal disease.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Renal cell carcinoma is the seventh most common malignancy
affecting adults in United States and had an estimated 54390 new
cases and 13310 deaths in 20081 With the advancement and
widespread use of imaging techniques such as CT, MRI and
sonography, the proportion of incidentally discovered tumors in
asymptomatic individuals has risen steadily.2 The proportions of
incidentally discovered tumors were only 10% in early 1970s which
has risen to 60% in 1990s.3
The aims of imaging techniques are not only to detect but
also to correctly stage the primary tumor with regard to tumor
size, location, organ conﬁnement, presence and extent of
tumor thrombus in vena cava and to identify lymph node and or
visceral metastasis.4CT scan is now the main imaging technique
for the evaluation of the intra abdominal component of renal
tumors.5
Surgery is considered to be the main form of curative treatment
of both localized and advanced renal cell carcinoma. For the patientO Box 3500, Stadium Road,
þ92 21 493 4294.
er).
ciates Ltd. Published by Elsevier Ltcounseling and planning of surgical approach and strategy, there-
fore preoperative imaging has a vital role.6 Many variables have
been regarded as prognostic indicators in RCC, the most important
of which being tumor size, stage and histological types. RCC can be
histo pathologically classiﬁed into clear cell RCC (CCRCC), papillary
RCC (PRCC), chromophobe (Ch RCC), collecting duct (Cd RCC) and
unclassiﬁed tumors.7
MDCT has been a major advancement in imaging, with very thin
slice collimation, high speed of acquisition and allowing refor-
matting of imaging in any planes which can provide excellent
anatomical details.8,9
The aim of this present study is to compare the predictability of
MDCT scan ﬁndings with the histopathological results in providing
the anatomical information to properly stage the RCC in subset of
patients who were treated with open radical nephrectomy at
a single centre.
2. Materials and methods
This is a retrospective analysis of data over a period of 2 1/2 years from January
2007eOctober 2009. The radiological, clinical and pathological data of all patients
who were treated by open radical nephrectomy for RCC were reviewed. All adult
patients with proven RCC by histopathological examination for which surgery was
done at our institute who had triphasic enhanced MDCT scan done preoperatively
within 2 weeks prior to surgery were included. Patients with renal tumor other than
adenocarcinoma, whose surgery was done in an outside hospital, those withd. All rights reserved.
Fig. 1. Comparison of result of MDCT with per operative ﬁndings and histopathological assessment of capsular invasion, adrenal gland involvement, renal vein thrombus, and vena
cava thrombus and lymph node involvement.
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numbers of radical, partial and cyto-reductive nephrectomies done during this
period at our institute were 126, however using the criteria, the ﬁnal study pop-
ulation consisted of 98 patients.
All CT examinations were performed on Aquilion 64, Toshiba. CT scans were
obtained with renal protocol i.e. un-enhanced sections through the renal area,
arterial phase and parenchymal (cortico medullary) phase. The following parame-
ters were used; slice thickness0.5 mm, collimation0.5 mm, reconstruction interval
5  5 mm and gantry rotation 0.5 s 80e100 ml of intravenous contrast was given to
all patients through peripheral venous access at a rate of 1.5 ml/s with a start delay of
40 s. Multi planar reconstructionwas done in standard abdomen algorithm provided
by the Toshiba as default setting to evaluate the tumor and its relationships with
the adjacent organs and structures. CT scan examinations were re-reviewed in
a purposeful manner, by a single investigator on a working station (Vitrea 2, Vital
connect, Toshiba) who was not aware of histopathological report, to assess tumor
invasion beyond the capsule into the perinephric fat, maximum radiological diam-
eter (MRD), involvement of adrenal gland by tumor or tumor thrombus involving
the renal vein and IVC (Fig. 1). By using the diameter of at least 1 cm as well as
contrast enhancement, the hilar lymph nodes were commented on whether
involved by tumor or not radiologically. The routine practice at our institute in open
radical nephrectomy is to remove only hilar lymph nodes without any extensive
lymph node dissection.
The operative notes were reviewed from medical records and Pathology
reports including both gross and microscopic description were analyzed and
where necessary, slides were re-reviewed with histo-pathologist. Tumor size was
recorded as maximum pathological diameter (MPD). The histological type of
RCC and its grade were also noted according to Fuhrman grading. The
radiological ﬁndings were compared with operative and pathological ﬁndings. All
tumor were staged both radiologically and pathologically using TNM staging
system (TNM-UICC 200210) as follows: T1a, less than 4 cm; T1b, 4 cm or more but
less than 7 cm; and T2, larger than 7 cm. The percentage reduction/increase in
tumor size (TSR) was determined by using formula 1-(MPD/MRD) and either
down staging or upstaging of tumor was determined by comparing the radiographic
stage and pathological stage.11 All clinical, radiological and histopathological data
were collected and analyzed on Statistical Package for Social Sciences (SPSS) version
16 and on Epi Info. Qualitative variables were compared using Pearson Chi square
test and 2  2 test and Student t test was used to compare quantitative variables.
P < 0.05 was considered statistically signiﬁcant in all analyses. The sensitivity,
speciﬁcity, (positive and negative predictive values) PPV and NPV of CT scan for
variables studied were determined from histopathological and per operative
ﬁndings.3. Results
The mean age of the population was 57.6  12.7 (22e81 years).
There were 34% women and 66% men. The mean age between men
and women were 57.8 þ 13 and 55.6 þ 12.5 years respectivelywhich was not statistically different (p ¼ 0.415). The surgical
approaches were ﬂank in 73 (74%), midline in 14 (14%), Chevron in 3
(3%) and Hemi-chevron in 8 (8%) patients. The Fuhrman grading
indicates that 11, 61 and 28% of tumors had grade I, II and III
respectively.
Majority of RCCwere clear cell 74 (75.5%) type, papillary were 14
(14.3%), 6 (6%) chromophobe and 2 (2%) each of collecting duct and
unclassiﬁed type. The mean MRD for all tumors was 7.51 þ 2.8
(2.6e16.0) cm andmeanMPDwas 7.13þ 2.0 (2.0e18.0) cm, and the
difference in sizes was statistically signiﬁcant (p 0.005). The
average MRD was 7.74, 6.25, 7.43, 7.3 and 8.35 cm for CCRCC, PRCC,
ChRCC, CdRCC and unclassiﬁed RCC respectively. The correspond-
ing values for average MPD were 7.29, 5.82, 7.88, 7.5 and 8.0 cm.
Overall 61 (61.2%) tumors showed lesser size on pathological
assessment compared to radiological assessment (Table 1).
With respect to size of primary tumor, among 74 CCRCC,10 were
stage T1a, 34 stage T1b and 30 were T2 by pathological staging
Fig. 2 and when radiological and pathological stages were
compared 21 tumor were down staged (8 from stage T1b toT1a and
13 from stage T2 to T1b) and only one tumor up staged from T1a to
TIb. Similarly 3 tumors from PRCC showed down staging while
ChRCC, CdRCC or unclassiﬁed RCC did not show any down staging
or upstaging. (Table 2)
Adequate information from pathology reports was available for
analysis of capsular invasion in all 98 tumors. The sensitivity,
speciﬁcity, PPV and NPV of CT scan for capsular invasion were 68%,
85%, 76% and 81% respectively. The hilar lymph nodes were avail-
able in histopathological specimen of 37 (38%) patients. CT scan had
sensitivity, speciﬁcity, PPV and NPV for hilar lymph nodes of 77%,
82%, 67% and 88.2% respectively.
Adrenal glands were present in 65 (66%) specimens, excluding
33 patients who had adrenal sparing radical nephrectomy and
sensitivity, speciﬁcity, PPV and NPV of CT scan were 100%, 98.33%,
83.33% and 100% respectively for adrenal involvement on CT
and pathology. Renal vein invasion and IVC tumor thrombus
status was determined on histopathology and per operatively in
all 98 patients. CT scan sensitivities, speciﬁcities, PPVs and
NPVs were 84.2%, 97.5%, 89% and 96.3% for renal vein invasion and
100%, 97.77%, 80% and 100% for IVC tumor thrombi respectively.
(Table 3)
Table 2
Radiologic and pathologic stage difference of renal tumors.
Histological
type
Tumors by
radiologic
stage (N)
Tumors by
pathologic
stage (N)
Down staged
tumors (N)
Upstaged
tumors (N)
CCRCC T1a 3 T1a 10 T1beT1a ¼ 8 T1aeT1b ¼ 1
T1b 28 T1b 34 T2eT1b ¼ 13 T1beT2 ¼ 0
T2 43 T2 30
PRCC T1a 2 T1a 3 T1beT1a ¼ 2 T1aeT1b ¼ 1
T1b 8 T1b 7 T2eT1b ¼ 1 T1beT2 ¼ 1
T2 4 T2 4
ChRCC T1a 1 T1a 1 T1beT1a ¼ 0 T1aeT1b ¼ 0
T1b 1 T1b 1 T2eT1b ¼ 0 T1beT2 ¼ 0
T2 4 T2 4
CdRCC T1a ee T1a ee T1beT1a ¼ 0 T1aeT1b ¼ 0
T1b 1 T1b 1 T2eT1b ¼ 0 T1beT2 ¼ 0
T2 1 T2 1
UNCLASSIFIED
RCC
T1a ee T1a ee T1beT1a ¼ 0 T1aeT1b ¼ ee
T1b 1 T1b 1 T2eT1b ¼ 0 T1beT2 ¼ ee
T2 1 T2 1
TOTAL T1a 6 T1a 14 T1beT1a ¼ 10 T1aeT1b ¼ 2
T1b 39 T1b 44 T2eT1b ¼ 14 T1beT2 ¼ 1
T2 53 T2 40 e
Table 1
Tumor size reduction of each histological type of renal cell carcinoma.
Malignant
histological type
Tumors
(N)
Average
MRD(cm)
Average
MPD (cm)
Reduced in
size tumors (N)
Average
TSR (%)
CCRCC 74 7.74 7.29 48 (64.8%) 5.81%
PRCC 14 6.25 5.82 9 (64.3%) 6.9%
Ch RCC 6 7.43 7.83 3 (50%) 5.4%
Cd RCC 2 7.3 7.5 0 (0%) 2.74%
UNCLASSIFIED
RCC
2 8.35 8.0 2 (100%) 4.2%
TOTAL 98 7.51 7.13 61 (62.24%) 5.0%
MRD ¼ mean radiologic diameter, MPD ¼ mean pathologic diameter, TSR ¼ tumor
size reduction ¼ 1- (MPD/MRD).
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In the current work, we examined the reliability and accuracy of
CT scan for giving staging information in patients with RCC, keeping
ﬁnal pathology report as a point of reference. CT scan is regarded as
a highly accurate measure (sensitivity 100%, speciﬁcity 95%) for
detection of renal masses using the proper technique and
protocol.12 There are studies that have demonstrated the accuracy
of CT scan for detection and staging of renal masses to be up to 91%
making it the imaging modality of choice.6
Multidetector CT has the added advantage of better resolution
because of thin collimation enabling reconstruction of coronal and
sagittal planes in addition to the generation of volumetric images.
The reformation was also possible with single detector CT but the
resolution for multidetector CT is far superior which makes the
evaluation accurate for detection and staging of renal tumors.
Multidetector CT also allows better visualization of renal vascular
anatomy and involvement of renal vein and IVC by the tumor. The
involvement of peri-renal fat and the adrenal gland is also better
appreciated by the MDCT as compared to single detector CT.8,13 MRI
has the advantage of superior soft-tissue contrast, which provides
a powerful tool in the detection and characterization of renal
lesions. Currently 1- to 1.5-T systems are generally used for
abdominal imaging, but the advent of 3-T MRI systems brings
a twofold increase in the signal-to-noise ratio (SNR). However,
although 3-T MRI is promising, only a limited amount of research
has been published on 3-T MR imaging for renal lesions, and its
value has still to be established.14 Staging is usually performed
using CT. Hallscheidt compared the performance of CT and MRI inFig. 2. Reduction/increase in sithe TNM system and found a similar accuracy in the staging of renal
cell carcinoma.15
Tumor size, stage and histological type are known to be an
important prognostic variable for RCC16,17 Many studies have shown
the discrepancy in size of tumor on preoperative imaging compared
to post operative pathological specimen size.11,18,19 These studies
have noted down sizing of the tumor onpathological evaluation. The
pathological size is an important indicator for prognosis of patients;
however, radiological size estimation is an essential component for
selecting the appropriate treatment in RCC i.e. radical or partial
nephrectomy. Decrease in volume of blood in a highly vascular renal
tumor after ligation or occlusion of renal artery has been postulated
as a cause for reduction in tumor size onpathological examination.20
The shrinkage in tumor size can also be a result of 10% buffered
Formalinwhichwasused forﬁxationof pathological specimen in our
study. CT scan can accurately predict the tumor sizewith only 0.5 cm
difference compared to pathological size.18,20 We have similarly
found average decreases in size of specimen of RCC of 0.38 cmwhich
was statistically signiﬁcant (p 0.005). Althoughwehave not analyzed
the factors responsible for this signiﬁcant difference between
radiological and pathological sizes, Yaycioglu et al18 noted that theze on pathological staging.
Table 3
Sensitivity, speciﬁcity and predictive values of various anatomical parameters of renal cancer on radiologic and pathological evaluation.
Variable
Studied (N)
Capsular invasion Lymph node
involvement
Renal vein
involvement
IVC involvement Adrenal gland
involvement
98 37 98 98 65
Sensitivity (%) 67.6 77 84.2 100 100
Speciﬁcity (%) 85.2 82 97.5 97.8 98.3
PPV (%) 75.3 66.7 89 80 83.3
NPV (%) 81.3 88.2 96.3 100 100
CT þve HP þve HP ve HP þve HP ve HP þve HP ve Op þve Op ve HP þve HP ve
25 9 10 9 16 2 8 2 5 1
CT ve HP þve HP ve HP þve HP ve HP þve HP ve Op þve Op ve HP þve HP ve
12 52 6 12 3 77 0 88 0 59
IVC ¼ Inferior vena cava, HP ¼ Histopathological ﬁnding, Op ¼ Per operative ﬁnding, CT þve ¼ reported on CT scan, CT ve ¼ Not reported on CT.
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phritis, and tumor invasion into the collecting system and locally
advanced RCC, as inﬂuencing factors responsible for this reduction in
size in the pathological specimen compared to radiological size.
Kanofsky et al11 in their study showed that 59% of CCRCC showed
regression after excision and greatest reduction in size was also
observed in pts with CCRCC. The reduction in size of tumor was
enough to downstage the tumor by TNM system in 16% of specimen
with regression. Based on this ﬁnding, they have postulated that
worsened size/stage stratiﬁed disease speciﬁc survival is due to this
artiﬁcial down staging of CCRCC as compare to other subtypes. In our
study 65% of CCRCC showed tumor regression however, only 44% of
them had down staging of tumor by TNM system. This difference in
size of tumor and regression from T2-T1 and T1b- T1a; however, has
no impact on surgical strategy and management of patients. The
greatest reduction in tumor size was observed with PRCC. Only one
tumor (CCRCC) showed upstaging.
In a cross sectional imaging it is difﬁcult to distinct b/w RCCwith
or without renal capsular invasion.21 CT scan showed sensitivity of
only 67% as compare to histological examination with respect to
capsular invasion. Capsular invasion is however very difﬁcult to
diagnose as reported in different studies. In a study, half of the
patients with stage I (T1-T2) disease were found to have peri-renal
stranding and thickening of fascia secondary to perinephric edema,
fat necrosis and inﬂammatory changes owing to previous stone
disease or inﬂammation which can give rise to false positive
diagnosis.22
Nodal involvement is one of the factors inﬂuencing the prog-
nosis of patients with RCC. The extent of lymphadenectomy during
radical nephrectomy is not clearly deﬁned in contemporary litera-
ture. Extended lymphadenectomy does not improve survival in
patients with clinically undetectable lymph nodes and should be
restricted to staging purposes in palpable and CT detected enlarged
lymph nodes23 Identiﬁcation of lymph node metastasis has been
a signiﬁcant problem with the axial CT scans and are still based on
size criteria only, limiting the size to 10 mm. Johnson et al showed
that CT scan had an accuracy of 83e88% for lymph nodes of at least
1 cm in diameter, which contained tumor on histopathology.24
Axial CT scan had a false negative rate of about 10% and a false
positive rate of up to 58% mainly due to reactive hyperplasia.25
Catalona et al6 showed that MDCT with thin collimation and
multi-planer reformatting resulted in diagnostic accuracy with
false positive rate only 6.3% due to reactive hyperplasia. Our series
has shown similar results with sensitivity of 77% and speciﬁcity of
82% for lymph node positivity on histopathology.
Nearly 15e25% of patients have venous invasion and tumor
thrombus at the time of diagnosis which warrants accurate iden-
tiﬁcation and exact extent of thrombus for planning correct surgical
approach. MRI has replaced and is superior to all other invasive and
non invasive imaging modalities in identifying the cranial extent ofthrombus and differentiating between bland thrombus and tumor
thrombus.4 Our results have shown sensitivity of 84.2% and speci-
ﬁcity of 97.5% for renal vein and sensitivity of 100% with speciﬁcity
of 97.8% for IVC involvement. Out of 2 cases with supra-diaphrag-
matic involvement of IVC, CT scan missed one.
The current surgical trend is to spare adrenal gland during
surgery for RCC because of low incidence (1.2e8.5%) of metastasis
to ipsilateral gland. The relationship of adrenal gland to renal
neoplasm can be better visualized on MDCT using coronal refor-
matted images6 and studies have shown speciﬁcity and NPV of this
modality to be nearly 10.26e28 Our data showed similar results with
speciﬁcity and NPV of 98% and 100% respectively.
In conclusion, CT scan can detect size of renal masses within
0.5 cm of its histopathological size (which determines the stage)
however a signiﬁcant number of tumors were down staged on
pathology. CT scan has high speciﬁcity for capsular invasion, nodal
disease, and renal vein and IVC tumor thrombus but has poor sensi-
tivity for capsular invasion and lymph node involvement by tumor.
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